Ondansetron HCL 8 MG tablet 30S
Ended Awarded
- Contract number
- SPE2DB25FD11G
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $27,579
Award facts
- Contract value 100% obligated
- $27,579.44 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $27,579.44 to AmerisourceBergen Drug Corp for the supply of Ondansetron HCL 8 mg tablets (30-count units). This competitively awarded, firm fixed-price contract with no set-aside designation is scheduled for completion by September 26, 2025, and will be performed at the vendor's corporate office in Conshohocken, Pennsylvania. Ondansetron is a widely used antiemetic medication commonly procured for military and veteran healthcare systems to manage nausea and vomiting.
This delivery order operates under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (designated SPE2DX), valued at $999,999,999.00 through December 2026. As a major pharmaceutical distributor and critical federal medical vendor, AmerisourceBergen leverages this comprehensive global pharmaceutical support vehicle to supply a broad range of medications, vaccines, medical devices, and specialized healthcare commodities to support Defense Health Agency, U.S. Coast Guard, and other government healthcare systems worldwide. The company's demonstrated capability to fulfill federal procurement requirements through open competition, combined with its extensive portfolio of pharmaceutical deliveries, positions it as a key supplier within the DLA's medical supply chain operations.
Quick answers
Who was awarded contract SPE2DB25FD11G?
SPE2DB25FD11G was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on September 25, 2025.
How much is contract SPE2DB25FD11G worth?
The government has obligated $27,579 on SPE2DB25FD11G.
Is contract SPE2DB25FD11G an order under another contract?
Yes. SPE2DB25FD11G is a delivery order under SPE2DB20D2014, an indefinite delivery contract.
Was contract SPE2DB25FD11G competed?
The extent of competition for SPE2DB25FD11G was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award